Female Representation in Ophthalmic Oncology and Pathology: An Analysis of Scholarship and Leadership
- PMID: 40225966
- PMCID: PMC11991721
- DOI: 10.1159/000542560
Female Representation in Ophthalmic Oncology and Pathology: An Analysis of Scholarship and Leadership
Abstract
Introduction: Female representation in ophthalmic oncology and pathology is unknown. We evaluated gender-based trends in authorship and leadership in these fields, focusing on intraocular tumors.
Methods: Articles containing "uveal melanoma" (UM), "retinoblastoma" (Rb), "primary intraocular lymphoma" (PIOL), "choroidal metastasis" (CM), and articles in Ocular Oncology and Pathology (OOP) were searched on PubMed and author names obtained. Leadership/awards from 4 international ophthalmic oncology and pathology societies were recorded. GenderAPI was used to predict gender.
Results: Among 4,245 UM, 9,660 Rb, 141 PIOL, 353 CM, and 568 OOP authors, more males were first (range, 52-67%) and last authors (range, 69-76%). Analysis of the 4 keywords showed overall female authorship increased from 2011 to 2016 to 2017-2022 (35%-40%, p < 0.001), with an increase in both first (45%-47%, p = 0.03) and last authorship (26%-33%, p < 0.001). Female first authors were more likely to publish with female last authors (Rb OR 1.72, p < 0.001; OOP OR 2.04, p = 0.01). Males held more leadership roles/awards in societies.
Conclusion: Female representation in ophthalmic oncology and pathology has grown but gender disparities remain. Female first authors were more likely to publish with female last authors. Most society leaders and awardees were male. Cultivating mentorship through professional organizations may help achieve gender parity.
Keywords: Choroidal metastasis; Diversity-Equity-Inclusion; Female representation; Gender; Ocular oncology; Ocular pathology; Ophthalmic oncology; Ophthalmic pathology; Primary intraocular lymphoma; Retinoblastoma; Uveal melanoma.
© 2024 S. Karger AG, Basel.
Conflict of interest statement
A.H.S. and P.M. are consultants for Castle Biosciences Inc. The remainder of the authors has no conflicts of interest to declare.
Figures






Similar articles
-
Gender Disparities in Academic Otolaryngology.Laryngoscope. 2024 May;134(5):2144-2152. doi: 10.1002/lary.31217. Epub 2024 Feb 15. Laryngoscope. 2024. PMID: 38358356
-
Analysis of authorship trends in vascular surgery demonstrates a sticky surgical floor for women.J Vasc Surg. 2022 Jan;75(1):20-28. doi: 10.1016/j.jvs.2021.07.228. Epub 2021 Aug 25. J Vasc Surg. 2022. PMID: 34450243
-
Female leadership in oncology-has progress stalled? Data from the ESMO W4O authorship and monitoring studies.ESMO Open. 2021 Dec;6(6):100281. doi: 10.1016/j.esmoop.2021.100281. Epub 2021 Oct 19. ESMO Open. 2021. PMID: 34924143 Free PMC article.
-
Neuro-oncology authorship trends in gender since 1944: a systematic review of 14,020 articles from five top-tier academic journals.J Neurosurg. 2022 Nov 25;139(1):1-10. doi: 10.3171/2022.10.JNS221183. Print 2023 Jul 1. J Neurosurg. 2022. PMID: 36433875
-
A 20-year analysis of gender trends in oncology authorship in the Cochrane database of systematic reviews.Front Oncol. 2024 Oct 15;14:1450475. doi: 10.3389/fonc.2024.1450475. eCollection 2024. Front Oncol. 2024. PMID: 39474110 Free PMC article.
References
-
- Burton E, Jebaraj A, Eddington D, Brintz BJ, Simpson RG, Pettey JH. Gender representation among presenters in ophthalmology subspecialties in 2019: a retrospective review. Am J Ophthalmol. 2022;242:18–25. - PubMed
-
- Gill HK, Niederer RL, Shriver EM, Gordon LK, Coleman AL, Danesh-Meyer HV. An eye on gender equality: a review of the evolving role and representation of women in ophthalmology. Am J Ophthalmol. 2022;236:232–40. - PubMed
-
- Colleges AoAM . 2022Physician specialty data report 2022.
-
- Mansour AM, Shields CL, Maalouf FC, Massoud VA, Jurdy L, Mathysen DG, et al. . Five-decade profile of women in leadership positions at ophthalmic publications. Arch Ophthalmol. 2012;130(11):1441–6. - PubMed
LinkOut - more resources
Full Text Sources